Literature DB >> 23825351

Stability-indicating LC method for the estimation of bendamustine hydrochloride and its related impurities.

Srinivasulu Kasa1, M Raja Sekhar Reddy2, Raja Sekhar Kadaboina2, Veerender Murki2, Venkata Suryanarayana Mulukutla3.   

Abstract

A novel, simple, sensitive and stability-indicating high-performance liquid chromatography method was developed and validated for the quantification of impurities (process related and degradants) and the assay determination of Bendamustine hydrochloride. A chromatographic separation of Bendamustine and its impurities was achieved with an Inertsil ODS-2 analytical column, 250 × 4.6 mm, 5 µm, using gradient elution with mobile phase A consisting of a mixture of water and trifluoroacetic acid (1000:1, v/v) and mobile phase B consisting of acetonitrile. The instrumental settings included a flow rate of 1.0 mL/min, column temperature of 27°C and a detector wavelength of 233 nm, using a photodiode array detector. The tailing factor for Bendamustine was 1.10. Bendamustine hydrochloride was exposed to thermal, photolytic, hydrolytic and oxidative stress conditions and the stressed samples were analyzed by the proposed method. Peak homogeneity data of Bendamustine were obtained by using a photodiode array detector in the stressed sample chromatograms, which demonstrated the specificity of the method for estimation in the presence of degradants. The developed method was validated for parameters such as precision, accuracy, linearity, limit of detection, limit of quantification, ruggedness and robustness. The stability tests were also performed on drug substances as per International Conference on Harmonization guidelines.
© The Author [2013]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23825351     DOI: 10.1093/chromsci/bmt075

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  2 in total

1.  Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).

Authors:  Therasa Kim; He Yun Choi; Hyun-Seo Lee; Sung-Hoon Jung; Jae-Sook Ahn; Hyeoung-Joon Kim; Je-Jung Lee; Hee-Doo Yoo; Deok-Hwan Yang
Journal:  BMC Cancer       Date:  2018-07-09       Impact factor: 4.430

2.  Determination of Bendamustine in Human Plasma and Urine by LC-FL Methods: Application in a Drug Monitoring.

Authors:  Alina Plenis; Agnieszka Frolow; Natalia Rekowska; Ilona Olędzka; Piotr Kowalski; Ewa Bień; Małgorzata Anna Krawczyk; Elżbieta Adamkiewicz-Drożynska; Tomasz Bączek
Journal:  Chromatographia       Date:  2016-05-18       Impact factor: 2.044

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.